InMode/$INMD

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About InMode

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.

Ticker

$INMD
Primary listing

Industry

Health Care Equipment & Supplies

Headquarters

Yokne'am, Israel

Employees

599

ISIN

IL0011595993

InMode Metrics

BasicAdvanced
$960M
6.62
$2.29
1.96
-

What the Analysts think about InMode

Analyst ratings (Buy, Hold, Sell) for InMode stock.

Bulls say / Bears say

InMode's substantial cash reserves of approximately $800 million, representing 55% of its market capitalization, provide a strong financial foundation for potential strategic investments or shareholder returns. (stocktitan.net)
The company's high gross margins of around 80% and healthy free cash flow indicate efficient operations and profitability. (stocktitan.net)
InMode's recent Health Canada certification of the IgniteRF Platform with QuantumRF Technology opens new market opportunities in Canada, potentially driving revenue growth. (finance.yahoo.com)
InMode reported a 3% year-over-year revenue decline in Q1 2025, with revenue falling to $77.9 million from $80.3 million, indicating potential challenges in maintaining growth. (stocktitan.net)
The company lowered its full-year 2025 revenue guidance to between $395 million and $405 million, down from previous estimates, reflecting concerns over future performance. (stocktitan.net)
Barclays reduced its price target for InMode from $27.00 to $26.00, suggesting tempered expectations for the stock's performance. (etfdailynews.com)
Data summarised monthly by Lightyear AI. Last updated on 9 Jul 2025.

InMode Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

InMode Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $INMD

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs